Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 6Leukemia, Myeloid, Acute 3Leukemia 3Invasive Fungal Infections 3Infections 3Mycoses 2Drug-Related Side Effects and Adverse Reactions 2Wilms Tumor 1Testicular Neoplasms 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroblastoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Neutrophilic, Chronic 1

Interventions

liposomal amphotericin B 1Voriconazole 1Caspofungin 1Blood Specimen Collection 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Invasive Pulmonary Aspergillosis × Voriconazole × Clear all
NCT01148160 2014-04-10

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Asan Medical Center

Terminated
10 enrolled
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms, Invasive Pulmonary Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡